Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 6/20 | 0.54 |
| ▸ | MPO | P05164 | 1/20 | 0.46 |
| ▸ | DAO | P14920 | 1/20 | 0.45 |
| ▸ | BRD4 | O60885 | 1/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | KCNN4 | O15554 | 2/20 | 0.42 |
| ▸ | GPR52 | Q9Y2T5 | 2/20 | 0.41 |
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | CETP | P11597 | 1/20 | 0.41 |
| ▸ | AKT2 | P31751 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.40 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31414967 | 0.80 | TAAR1 (0.75) | TAAR1BRD4HTR1A | |
| SCHEMBL5009648 | 0.78 | DAO (0.55) | MPODAOSLC6A4CETPCHRM2 | |
| SCHEMBL7417625 | 0.76 | TAAR1 (0.55) | TAAR1HTR1A | |
| Hydrochloric Acid SCHEMBL10944343 | 0.75 | TAAR1 (0.54) | TAAR1HTR1A | |
| SCHEMBL10719843 | 0.74 | TAAR1 (0.66) | TAAR1DAOHTR1A | |
| SCHEMBL27160490 | 0.73 | KCNN3 (0.47) | MPODAOSLC6A4KCNN4GPR52 | |
| SCHEMBL535567 | 0.73 | TAAR1 (0.64) | TAAR1BRD4HTR1ARAB9A | |
| SCHEMBL535040 | 0.73 | TAAR1 (0.64) | TAAR1DAOHTR1A | |
| SCHEMBL10463711 | 0.73 | TAAR1 (0.64) | TAAR1HTR1A | |
| SCHEMBL3749613 | 0.73 | TAAR1 (0.64) | TAAR1DAOHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180301640-A9 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2018-10-18 | — | — | US | disclosed |
| US-20160380214-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2016-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160380214-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | L1CAM, AP1M1, L3MBTL1 | TAAR1 1667/4885MPO 550/4885DAO 3882/4885 |
| US-20180301640-A9 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | L1CAM, AP1M1, L3MBTL1 | TAAR1 1667/4885MPO 550/4885DAO 3882/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.